According to STAAR Surgical's latest financial reports and stock price the company's current Operating Margin is 16.10%. At the end of 2022 the company had an Operating Margin of 16.11%.
Year | Operating Margin | Change |
---|---|---|
2022 | 16.11% | 18.57% |
2021 | 13.58% | 168.56% |
2020 | 5.06% | -41.69% |
2019 | 8.67% | 61.94% |
2018 | 5.36% | -311.37% |
2017 | -2.53% | -83.21% |
2016 | -15.10% | 107.72% |
2015 | -7.27% | -36.96% |
2014 | -11.53% | -847.35% |
2013 | 1.54% | -289.58% |
2012 | -0.81% | -118.89% |
2011 | 4.31% | -164.32% |
2010 | -6.70% | 7.19% |
2009 | -6.25% | -78.41% |
2008 | -28.94% | 13.34% |
2007 | -25.53% | 6.38% |
2006 | -24.00% | 23.64% |
2005 | -19.41% | -2.09% |
2004 | -19.82% | 39.66% |
2003 | -14.19% | -15.7% |
2002 | -16.84% | -53.63% |
2001 | -36.31% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Novartis NVS | 17.27% | 7.27% | ๐จ๐ญ Switzerland |
Abbott Laboratories ABT | 15.60% | -3.11% | ๐บ๐ธ USA |
Cooper Companies COO | 14.36% | -10.81% | ๐บ๐ธ USA |
Atrion ATRI | 23.28% | 44.60% | ๐บ๐ธ USA |
SurgePays SURG | 3.87% | -75.96% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.